NSUR 279 introduces graduate and undergraduate students (target audience are lifescience/medical-, engineering and business students) from various backgrounds to the development and market issues specific to drug-device combination products.

The course consists of 2 parts:

1. Weekly seminar series, with special emphasis on the regulatory requirements for drug device combinations as well as the specific aspects of IP and reimbursement issues facing drug device combinations. In addition, there will be a series of case studies presented by guest speakers.
2. Interdisciplinary team study project, in which students are provided with a specific drug device-combination project, for which the team will have to put together an appropriate product development strategy and timeline.

2 units – Seminar Series
4 units – Seminar Series PLUS Team Project

Winter Quarter: Mondays 4:05-6:15 pm

n/a

Poster and Final Paper for those involved in Team Project

Classroom: Peter Wallenberg Learning Theater (Rm 124) of Wallenberg Hall (Bldg 160); SE corner of Main Quad

The course can be taken for 2units for the seminar series only – or 4 units for the seminar series PLUS the team based project. It is highly recommended that the students participate in a team project.